万孚生物副总经理，转任董事

Core Viewpoint - The company announced the resignation of Vice President Kang Keren due to internal governance structure adjustments, but she will continue to serve in another capacity within the company [1][5]. Group 1: Management Changes - Kang Keren submitted a written resignation report to resign from her position as Vice President of the fifth board of directors [1][5]. - After her resignation, Kang Keren was elected as a representative director by the employee representative assembly, with her term lasting until the end of the current board's term [4][8]. Group 2: Background Information - Kang Keren, born in December 1976, holds a doctoral degree and is a senior engineer. She has been with the company in various roles since 2012 [4][8]. - As of the announcement date, Kang Keren holds 175,000 shares in the company, and her salary for 2024 is reported to be 1.0064 million yuan, a decrease of 326,400 yuan compared to 2023 [4][8]. Group 3: Financial Performance - For the first three quarters of 2025, the company reported a revenue of 1.690 billion yuan and a net profit attributable to shareholders of 134 million yuan [9].